22 September 2017 - - New York, New York-based type 1 diabetes (T1D) research funding organization JDRF will contribute funding to Toronto, Canada-based pre-clinical life sciences company Zucara Therapeutics Inc., the company said.
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
22 September 2017 - - US-based age-related afflictions treatment developer Unity biotechnology, Inc. has made recent additions to its executive team, the company said.
Joining as chief financial officer is Bob Goeltz. Goeltz was most recen...
Joining as chief financial officer is Bob Goeltz. Goeltz was most recen...
22 September 2017 - - A patient at Penn Medicine with head and neck cancer became the first person to be treated on the Halcyon system, the new platform for cancer treatment from Palo Alto, California-based cancer-focused medical devices and sof...
22 September 2017 - - Vancouver, British Columbia-based cell biology specialist Stemcell Technologies has signed an exclusive license agreement with Rockville, Maryland-based regenerative medicine company Propagenix to commercialise its pat...
22 September 2017 - - Santa Ana, California-based orthopaedic braces, rehabilitation products, and portable vascular therapy provider ManaMed Inc. has released its FDA-approved portable and tubeless sequential deep vein thrombosis (DVT) prevention de...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe